CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
The in vitro pharmacology of LY IGlar (LY2963016): A new insulin glargine product
DOI 10.1055/s-0036-1580997
Bibliografische Angaben
Nachweis in CareLit
Autor:innenRA Owens, SD Kahl, X Ruan, C Zhang, MW Farmen, JS Moyers, MD Michael
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Basal insulin analogs, with durations of action sufficient for coverage over the course of 24h, are important for the proper management of glycemic control in diabetic patients. LY2963016 (LY IGlar), an insulin analog has the same amino acid sequence as Lantus® (IGlar). The pharmacological properties of six independent lots of LY IGlar and IGlar were compared using a panel of in vitro biological assays to…
Zitieren
Zitierempfehlung
RA Owens, SD Kahl, X Ruan, C Zhang, MW Farmen, JS Moyers, MD Michael (2016) The in vitro pharmacology of LY IGlar (LY2963016): A new insulin glargine product. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580997
Mit CareLit weiterarbeiten